The US Department of Defense awarded Paragon Bioservices a $15 M contract to develop a large scale mammalian cell culture process to produce vaccines to filoviruses. This virus class has long been considered by DoD to be a potential biological weapon and in this case is focusing on the Venezuelan equine encephalitis (VEE) virus and related viruses like Ebola and Marburg.
US DoD awards CMO Paragon Bioservices $15m vaccine deal.
The DoD expects the contract to be completed in 2020 and it is just another step in a long standing program by the agency to protect the US from potential filovirus events.
Posted by Bruce Lehr Jan 18th 2012.
Comments